Navigation Links
A 'Knock-Out' Match: Kelly Ripa and Molly Sims Team Up to Fight Ovarian Cancer
Date:6/10/2008

iring women," said Bob Ayd, chief merchandising officer for QVC. "With their dedication to OCRF and positive influence on women everywhere, we look forward to bringing even more attention to this important cause."

"OCRF is thrilled to work with QVC again this year for the 11th Annual Super Saturday," said Faith Kates Kogan, president of OCRF. "With Kelly and Molly's endless support, combined with QVC's commitment to excellence, OCRF will continue its mission to raise much-needed funds for research and raise awareness of this deadly disease."

About QVC

QVC, Inc., a wholly owned subsidiary of Liberty Media Corporation attributed to the Liberty Interactive Group (Nasdaq: LINTA), is one of the largest multimedia retailers in the world, with annual revenue of more than $7 billion. QVC is committed to providing customers with thousands of the most innovative and contemporary beauty, fashion, jewelry and home products. Its programming is distributed to more than 166 million homes worldwide. The company's website, QVC.com, is ranked among the top general merchant Internet sites. With subsidiaries in the United Kingdom, Germany and Japan, West Chester, PA-based QVC has shipped more than a billion packages in its 21-year history.

About The Ovarian Cancer Research Fund

The Ovarian Cancer Research Fund (OCRF) is the leading independent, non-profit organization in the United States dedicated to advancing research, raising awareness and finding a cure for ovarian cancer. Ovarian cancer takes the lives of over 15,000 women in the United States each year, with over 20,000 new cases being diagnosed annually. There is currently no method of early detection, leading to late diagnosis in 75 percent of all cases. OCRF is committed
'/>"/>

SOURCE QVC, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Bacteria beware: MIT student invents knock-out punch for antibiotic resistance
2. Silica smart bombs deliver knock-out to bacteria
3. New knock-out gene model provides molecular clues to breast cancer
4. Pro Football Hall of Fame Member Jim Kelly Urges Congress to Approve the Newborn Screening Saves Lives Act
5. Texas Affiliates of Susan G. Komen for the Cure, Sen. Kirk Watson, Rep. Patrick Rose, Singer Kelly Willis, Breast Cancer Survivors and Activists Rally for Passage of Proposition 15
6. Have the Last Laugh on Allergies This Season: Actress Molly Shannon Teams with The Allergy Foundation to Talk About Allergies
7. Foods Co Continues Fight to Help End Hunger in America
8. Researchers ID Inflammation-Fighting Pathway in Fat Cells
9. Cantimer, Inc. Awarded $996,000 Contract from U.S. Government to Develop Portable, Real-Time and Non-Invasive Hydration Measurement and Monitoring System for Use by Firefighters
10. AIDS/LifeCycle Raises a Record $11.5 Million to Fight AIDS
11. Enzyme may hold key to improved targeting of cancer-fighting drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... 16 Smart Balance, Inc. (Nasdaq: SMBL ... authorized a two-year stock repurchase program of up to ... program demonstrates the confidence we have in the prospects ... long-term value for all of our shareholders, while at ... Stephen Hughes, Smart Balance, Inc. Chairman and Chief Executive ...
(Date:12/16/2009)... Immucor, Inc. (Nasdaq: BLUD ), a global leader ... industry, today announced that Paul D. Mintz, M.D. has ... director, effective January 1, 2010. ,, Dr. Mintz ... for more than 30 years. He is a tenured ... Virginia School of Medicine. He also serves as director ...
(Date:12/16/2009)... 16 As a result of C3: Colorectal ... peer reviewed cancer research program is included in the ... This new cancer research program will research cancers, like ... prostate, lung and ovarian cancer research programs run by ... ,, The $15 million in funding for this ...
(Date:12/16/2009)... teams led by the Wellcome Trust Sanger Institute announce ... All cancers are caused by mutations in the DNA ... lifetime. The studies, of a malignant melanoma and a ... the mutations in the genomes of two cancers. , ... year: almost all are associated with smoking. The number ...
(Date:12/16/2009)... Access to Quality, Cost-Effective Care , ... Washington, D.C. ... debated the best ways to rein in runaway costs while providing ... important part of the ongoing discussion includes how to ensure patients ... doctors of medicine (MDs) or osteopathy (DOs). In both the ...
Breaking Medicine News(10 mins):Health News:Smart Balance Authorizes Stock Repurchase Program 2Health News:Immucor Appoints New Board Director 2Health News:House Creates New Cancer Research Program 2Health News:House Creates New Cancer Research Program 3Health News:Lung cancer and melanoma laid bare 2Health News:Lung cancer and melanoma laid bare 3Health News:Lung cancer and melanoma laid bare 4Health News:Lung cancer and melanoma laid bare 5Health News:Lung cancer and melanoma laid bare 6Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 2Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 3Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 4Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 5
... reason why smoking is bad for health. ,It seems that ... that protects against heart disease in their blood. The discovery ... risk of heart attacks than non-smokers. ,Paraoxonase is ... and blocking the blood vessels. A team of Swiss researchers ...
... old age appears to be linked to intellectual impairment over ... the Institute of Psychiatry in London carried out a community ... than 630 people aged 65 and over. Smoking and drinking ... volunteers' intellectual powers were also assessed. After excluding those who ...
... analysis, it is better to give radiation therapy before surgery ... as surgery can reduce the risk of recurrence. Generally the ... Scandinavia and the Netherlands, the therapy is given before surgery ... afterwards.// ,An analysis of 8000 patients, led by ...
... The fear of biological weapons such as anthrax may be ... experts. Long-term social or psychological damage could be the result ... letter to the British Medical Journal from researchers in the ... not kill many people, for many more, their prospect is ...
... five times more likely to die at birth than those ... carried out by doctors in the north-west of England also ... more likely to have babies with birth defects. ,The ... that babies born to women with diabetes in Swden were ...
... who are most at risk from high blood pressure have ... being neglected. Doctors are often reluctant to treat people with ... high cholesterol or diabetes. Maybe they believe little can be ... or they may worry about lowering blood pressure in a ...
Other Medicine News:Health News:All the more bad, 2
(Date:12/16/2009)... Dec. 16 /PRNewswire/ -- Sanofi ... Group, announced today that it has entered ... Syntiron to develop and commercialize its prophylactic ... Staphylococcus aureus or MRSA. MRSA ... humans, sometimes referred to as multidrug-resistant ...
(Date:12/16/2009)... N.Y., Dec. 16 BioSpecifics Technologies Corp. ... first in class collagenase-based products, today announced top-line ... clinical trial of XIAFLEX(TM) for the treatment of ... presence of inelastic collagen on the shaft of ... make sexual intercourse difficult or impossible in advanced ...
(Date:12/16/2009)... -- CVS/pharmacy and MinuteClinic health care centers located ... vaccine in 20 states and Washington, D.C. ... H1N1 vaccines continue, many states have lifted restrictions, ... the shot while supplies last. In addition, ... available at MinuteClinic locations across the country on ...
Breaking Medicine Technology:Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 2Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 3Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections 4BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 2BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 3BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 4CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 2CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 3CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 4Hardship in Childhood May Affect Long Term Health 63195 1Hardship in Childhood May Affect Long Term Health 63195 2Newly identified enzymes help plants sense elevated CO2 and could lead to water wise crops 11131 1Newly identified enzymes help plants sense elevated CO2 and could lead to water wise crops 11131 2Newly identified enzymes help plants sense elevated CO2 and could lead to water wise crops 11131 3Scientists use nanosensors for first time to measure cancer biomarkers in blood 11129 1Scientists use nanosensors for first time to measure cancer biomarkers in blood 11129 2
... the 2008 International Conference of the American ... ... Forest Laboratories, Inc. and,Laboratorios Almirall, S.A. today presented results ... bromide, an,investigational treatment for chronic obstructive pulmonary disease (COPD).,Data from ...
... Synta,Pharmaceuticals Corp. (Nasdaq: SNTA ) today ... (formerly STA-4783), an investigational agent,currently in development ... stage IV metastatic melanoma patients treated with ... chemotherapy had a,statistically significant improvement in progression-free ...
Other Medicine Technology:Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 2Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 3Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 4Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 5Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma 2Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma 3Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma 4Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma 5Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma 6Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma 7
... use of guaiac as a test for the ... of phenolic compounds present in guaiac to quinones, ... If blood is present, the heme portion of ... manner, catalyzing the release of oxygen from hydrogen ...
... SENSA elitewas designed to improve patient compliance. ... and sample collection options make this fecal ... understand and complete. Diet guidelines are explained ... determine which foods and drugs are okay ...
... The Original MaybeMom™ Mini ... medical diagnostic instument which uses ... her personal menstrual/fertility cycle, including ... ovulation and menstruation to increase ...
... supporting the effectiveness and accuracy of the ... clinical studies. As a woman nears ovulation ... increases, thereby, elevating the salt in her ... is allowed to dry, crystalization occurs. The ...
Medicine Products: